**Core Concept**
The BRAF gene encodes for the B-Raf protein, a serine/threonine kinase involved in the MAPK/ERK signaling pathway. This pathway is crucial for cell proliferation, differentiation, and survival. Mutations in the BRAF gene, particularly the V600E mutation, can lead to uncontrolled cell growth and cancer.

**Why the Correct Answer is Right**
The V600E mutation in the BRAF gene results in the substitution of glutamic acid for valine at position 600. This mutation leads to the constitutive activation of the B-Raf protein, causing it to remain in an active state and continuously phosphorylate and activate downstream targets, such as MEK and ERK. This aberrant signaling leads to the development and progression of various cancers, including melanoma, colorectal cancer, and thyroid cancer.

**Why Each Wrong Option is Incorrect**
**Option A:** Not specified, but potentially incorrect if it implies BRAF mutations are exclusive to this option.
**Option B:** While other genes, such as KRAS and NRAS, are also involved in the MAPK/ERK pathway, they are not the primary target of BRAF mutations.
**Option C:** This option is vague and does not specify a particular gene or mutation.

**Clinical Pearl / High-Yield Fact**
The V600E mutation in the BRAF gene is a well-established biomarker for melanoma and is associated with a better prognosis and response to targeted therapies, such as vemurafenib.

**Correct Answer: C. Melanoma.**